Why the study?
The study was conducted to identify additional susceptibility genes for calcific aortic valve stenosis beyond previously identified causal genes.
The identification of IL6, ALPL, and NAV1 as new susceptibility genes for calcific aortic valve stenosis provides novel targets for therapeutic development.
Answers are grounded in this paper and cite their sources.
May inform CAVS therapeutic targets; extends genetic correlations with CAD and risk factors.
We aimed to identify additional susceptibility genes for CAVS. METHODS: A GWAS (genome-wide association study) meta-analysis of 4 cohorts, totaling 5115 cases and 354 072 controls of European descent, was performed. A TWAS (transcriptome-wide association study) was completed to integrate transcriptomic data from 233 human aortic valves. A series of post-GWAS analyses were performed, including fine-mapping, colocalization, phenome-wide association studies, pathway, and tissue enrichment as well as genetic correlation with cardiovascular traits. RESULTS: lead variant colocalized with higher pulse pressure and higher prevalence of carotid artery stenosis. Association results at the genome-wide scale indicated genetic correlation between CAVS, coronary artery disease, and cardiovascular risk factors. CONCLUSIONS: Our study implicates 3 new genetic loci in CAVS pathogenesis, which constitute novel targets for the development of therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Thériault et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: